Cargando…
Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
Since 2015, 170 small molecules, 60 antibody-based entities, 12 peptides, and 15 gene- or cell-therapies have been approved by FDA for diverse disease indications. Recent advancement in medicine is facilitated by identification of new targets and mechanisms of actions, advancement in discovery and d...
Autores principales: | Liu, Jinsha, Ting, Joey Paolo, Al-Azzam, Shams, Ding, Yun, Afshar, Sepideh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001105/ https://www.ncbi.nlm.nih.gov/pubmed/33802091 http://dx.doi.org/10.3390/ijms22062805 |
Ejemplares similares
-
Impact of non-proteinogenic amino acids in the discovery and development of peptide therapeutics
por: Ding, Yun, et al.
Publicado: (2020) -
Peptides to combat viral infectious diseases
por: Al-Azzam, Shams, et al.
Publicado: (2020) -
Therapeutic Advances in Oncology
por: Liu, Jinsha, et al.
Publicado: (2021) -
In Vitro Assays: Friends or Foes of Cell-Penetrating Peptides
por: Liu, Jinsha, et al.
Publicado: (2020) -
Current Advancement of Immunomodulatory Drugs as Potential Pharmacotherapies for Autoimmunity Based Neurological Diseases
por: Ashraf, Hajra, et al.
Publicado: (2022)